Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Míreanna Comhchosúla

• Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
  le: Chen, Z, et al.
  Foilsithe: (2016)
• Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
  le: Wang, Wei, et al.
  Foilsithe: (2016)
• Estimations of the Increasing Prevalence and Plateau Prevalence of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors Therapy
  le: Huang, Xuelin, et al.
  Foilsithe: (2012)
• Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options
  le: Jabbour, Elias J., et al.
  Foilsithe: (2013)
• Molecular Monitoring in Chronic Myeloid Leukemia: Response to Tyrosine Kinase Inhibitors and Prognostic Implications
  le: Jabbour, Elias, et al.
  Foilsithe: (2008)